MiOXSYS™ for Male Infertility
Male Infertility and Oxidative Stress
Male infertility is a significant medical condition in which oxidative stress is well known to play a substantial role. The company is leveraging its MiOXSYS research tool to develop a clinical application – known as MiOXSYS – to assess oxidative stress levels in infertile males. Oxidative stress is well established as a leading contributing factor to male infertility. Further, a significant proportion of male infertility remains unexplained in part because of the lack of standardized tests available to clinicians and researchers to assess oxidative stress. This lack of standardization has resulted in poor implementation of semen and plasma analysis around the world.
MiOXSYS and Male Infertility
The company has conducted proof of concept studies in male infertility with a leading center in the United States and determined that oxidation-reduction potential effectively measures oxidative stress levels in semen and seminal fluid. Semen analysis studies are routinely conducted to assess causes of infertility, so we expect clinicians and oxidative stress researchers to readily integrate MiOXSYS into routine use. Additional studies are now underway that will determine the MiOXSYS system’s performance in semen analysis as it relates to infertility.